Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00577356 · ClinicalTrials.gov registry record · Phase 2
Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer
A Phase 2 study, sponsored by Benaroya Research Institute.
- Terminated
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
NCT00577356: Clinical Trial Phase 2 study, sponsored by Benaroya Research Institute.
NCT00577356 is a Phase 2 study that was terminated before completion, run by Benaroya Research Institute. The registered enrollment target is 6 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00577356, a Phase 2 study, was terminated before completion, sponsored by Benaroya Research Institute.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what effects, good and bad, the combination of docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer before removal the prostate (prostatectomy).
Primary Outcome
CG1940/CG8711 was given along with docetaxel over a series of treatment prior to radical prostatectomy. Pathology of resected specimen was done to determine complete response, defined as no microscopic evidence of neoplastic cells in the resected specimen
Interventions
- DRUG Docetaxel
- BIOLOGICAL CG1940/CG8711
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
Why NCT00577356 stopped before completion
NCT00577356 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Docetaxel is the first listed.
NCT00577356 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00577356 about?
NCT00577356 is a clinical study titled "Docetaxel and Immunotherapy Prior to Prostatectomy for High-Risk Prostate Cancer". The purpose of this study is to find out what effects, good and bad, the combination of docetaxel with CG1940/CG8711 (immunotherapy drugs) have on destroying prostate cancer before removal the prostate (prostatectomy).
What is the current status of trial NCT00577356?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2008-02. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00577356?
The interventions under investigation include: Docetaxel (DRUG), CG1940/CG8711 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00577356?
This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00577356's enrollment target sits among peer trials
6 1996th of 2000 higher than 1 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia